Skip to main content
Clinical Trials/JPRN-UMIN000016952
JPRN-UMIN000016952
Completed
未知

Evaluation of intraindividual variability in hepatic CYP3A4 enzyme activity using endogenous markers in lung cancer patients treated with chemotherapeutic drugs and aprepitant - Evaluation of intraindividual variability in hepatic CYP3A4 enzyme activity using endogenous markers in lung cancer patients treated with chemotherapeutic drugs and aprepitant

Keio University Faculty of Pharmacy0 sites60 target enrollmentMarch 27, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Keio University Faculty of Pharmacy
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 27, 2015
End Date
March 31, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Keio University Faculty of Pharmacy

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who required other chemotherapy 2\)Patients who qre actively receiving inducer or inhibitor of CYP3A4 3\)Patients who qre actively receiving androgen or estrogen preparation 4\)Patients who qre actively receiving adrenal cortex hormone preparation without dexamethasone 5\)Patients who qre actively receiving blood transfusion

Outcomes

Primary Outcomes

Not specified

Similar Trials